EDIT Q4 2018 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+66.9% YoY

Gross Profit

-$27M-434.7% margin

Operating Income

-$26M-429.0% margin

Net Income

-$25M-409.4% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

-57.9%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$88,000

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$420M

Total Liabilities

$184M

Stockholders' Equity

$236M

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+66.9%
Gross Profit	-$27M	-$23M	-16.9%
Operating Income	-$26M	-$36M	+28.0%
Net Income	-$25M	-$36M	+30.8%